Life Science startups are unique opportunities that require years of development, extensive scientific expertise and significant investments. Successful companies improve millions of lives and produce high returns for investors. These high returns inevitably go hand in hand with high risk and high development costs.

The Accelerace team reduces risk by providing relevant commercial and strategic input based on its experience and discussions with its extensive network.  This allows you to focus more on the critical issues to develop and de-risk your project.  We provide customized 1:1 support and sparring for our founders based on the team’s collective bio-entrepreneurial experience. This is combined with a set of proven coaching tools & techniques, which were built by founders, for founders.

Our aim is to help build your company while supplying on the job training that will provide you with the skills needed to support the company’s continued growth.

Once Accelerace has assisted you in defining a clear de-risking path, we are able to offer a longer-term strategic advice option via the NOME network who provide access to world-class mentorship for selected projects.

What you get

Free intensive business training from business developers with industry expertise. We take no equity.

Access to NOME mentor network with world-class mentors and industry partners like Novo Nordisk Fonden

Learning Labs & workshops where you will get intensive training designed to maximize your potential

Get access to know-how from our corporate partners

Investment opportunity from Accelerace Invest or our partners

A founders pack with resources and tools worth EUR 150,000+ from Amazon, Microsoft, Rackspace and many more


The right product
It has to be more than just an idea. You must have a validated plan for how you will develop your product and you have defined a strategy for how it can be commercialized. Although it is not a requirement we prefer if you have already obtained preclinical proof of concept with your technology. Products based on a service and other types of non-product businesses are welcome, but the same principles apply.
The right team
Participating startups must have more than one full-time founder that is 100% focused on the core idea. They must be able to receive coaching and mentoring in English and stay committed to realizing their commercial goals. We are looking for visionary entrepreneurs with ambitions to change the future.

The team

Partner, Business Accelerator & Investment Manager
M: +45 29713979

Morten Heide, Ph.d.

Partner, Business Accelerator & Investment Manager
M: +45 21262430

Peter Birk, Ph.d.

Business Accelerator & Investment Manager
M: +45 31450060

Arvind M. Hundal, Ph.d.

Business Accelerator & Investment Manager
M: +45 40280048

Jón Ingi Benediktsson

Business Accelerator & Investment Manager
M: +45 22114857

Will Wright

Program Manager NOME
M: +45 50260586

Valentin Lubbe

Program Manager NOME US
M: 19106030366

Julie Siler

Ted Zoller

Accelerace is one of the most significant and influential accelerator-programmes in Europe. It is without a doubt a game changer in the Danish entrepreneurial eco-system.”

Ted Zoller, Vice President for Entrepreneurship, Ewing Marion Kauffman Foundation & Professor, Kenan-Flagler Business School

Novo Nordisk

At the Novo Nordisk Foundation, we are very pleased with the Nordic Mentor Network for Entrepreneurship (NOME) that Accelerace has established over the last year. Today NOME covers the entire Nordic region including life science start-ups from all Nordic countries and several high-level mentors in the network. NOME is surely on its way to become the beacon in the ecosystem that we had hoped for from the very beginning.

Thomas Alslev Christensen, Head of Operations, Novo Nordisk Foundation

Video Gallery

Frequently Asked Questions

View questions
I’ve already participated in other programs – why should I join yours?
Well, it's up to you - however here are the most obvious 5 reasons:1) We focus on late stage startups that are already on the market and we help them scale. Most other programs are incubators or early stage accelerators. 2) We match you directly with our leading corporate partners that are interested in your technology and which in return will offer your know-how, insights and expertise. 3) You'll get an extra ressource on your team and not just a mentor giving you ad hoc advices.  Our business accelerators & investors spend 180 hours with your startup. Now that's really something. 4) Think of it as a shortcut to the Northern European markets. Not only is our startup tech scene vibrant and booming, but we also offer a  hotbed for clean tech, food and life science and a gateway to the Nordic countries. Denmark is home to 22% of the scaleups in the Nordics – and together the Nordic countries have almost 6 times as many scaleups as the average country in continental Europe, and 9 times more than in Southern Europe. 5) Denmark is one of the most digitalized and innovative countries in Europe. Our bustling, creative startup scene has fostered some of the world’s most successful tech companies and disruptive startups within AI, big data, block chain, healthtech and IoT.
Do you take equity?
We don't take equity in your startup. What we ask for however, is your full commitment to the program through out the 6-8 months period. Easy peasy.
How are you funded?
Our program is partly funded by the Danish Government and leading Danish and International corporates with the goal to attract startup talents and create growth.
Do I need to move to Denmark to participate?
It's possible to take sprint 1 (the first 2 months of the program) remotely. After 2 months time we will assess your case individually and decide whether or not it makes sense for both parties that you relocate to Denmark.
How much time should I expect to spend on the program?
Our program is designed around challenges that companies at your stage experiences. Consider spending about 4-8 hours per week in average, plus time do business development related efforts with the corporate partners. This factor varies from company to company.


Draupnir Bio has developed a platform for exploring the glycome to develop novel therapeutics. The platform is based on array technology, protein chemistry and advanced carbohydrate chemistry.
Beatt is providing consultancy and project management within the life science sector facilitating projects across different disciplines, from biotech, business, design and art.
Accelerace Life Science & Biotech Accelerator
Immunitrack (Denmark) works in the field of immunological molecules such as: the neonatal Fc receptor FcRn and major histocompability molecules (MHC).
PanCryos (Denmark) aims to develop a next generation stem cell derived allogenic cell therapy (PanINSULA™) for Type 1 diabetes
Canna Therapeutics
Canna Therapeutic is a biotechnology company specializing in innovative treatments using medical cannabis
Antag (Denmark) is working on a promising hormone treatment to fight obesity.
For use in wound healing of chronic ulcers by treatment with autologous blood.
Reagents for cancer research.